Cardiovascular Inflammation Reduction Trial "CIRT"

Recruiting

Phase 3 Results N/A

Summary of Purpose

The Cardiovascular Inflammation Reduction Trial (CIRT) is a randomized clinical trial investigating whether taking low-dose methotrexate reduces heart attacks, strokes, or death in people with type 2 diabetes or metabolic syndrome that have had a heart attack or multiple coronary blockages. This trial is funded by the National Heart, Lung, and Blood Institute (NHLBI)/National Institutes of Health (NIH).

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 22 August 2017.

1 Apr 2013 1 May 2012 1 Dec 2018 1 Dec 2019 1 Jul 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator)
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment

Contacts

  • CIRT Study Information

    855-437-9330